Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment

Written By David Ritter

Lena-Luise Becker, Karen Agricola, David M. Ritter, Darcy A Krueger, David Neal Franz

Pediatric Neurology. 2024 Dec:161:73-75. doi: 10.1016/j.pediatrneurol.2024.08.009

Treatment of patients with cenobamate will lower mTOR inhibitor medication levels in patient with TSC.

https://www.pedneur.com/article/S0887-8994(24)00300-X/fulltext

David Ritter
Previous

Cenobamate's Efficacy for Seizure Treatment in Tuberous Sclerosis Complex
Next

Impact of Race in Missed Appointments in Pediatric Neurology Resident Clinic at a Large Tertiary Medical Center